BackCOSCIENS Biopharma Overview

COSCIENS Biopharma Other Current Assets

Track COSCIENS Biopharma's other current assets ($2.6M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$2.57M
↑ 158.15% YoYΔ $1.57M vs prior year quarter

Peer average / median

Loading

COSCIENS Biopharma Other Current Assets History

Loading

COSCIENS Biopharma vs. peers: Other Current Assets Comparison

Loading

COSCIENS Biopharma Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

COSCIENS Biopharma (CSCI) FAQ

The latest other current assets for CSCI is $2.6M as of June 2025. That compares with $990K in the prior-year period — up 158.1% year over year. Investors often review this figure alongside COSCIENS Biopharma's historical trend and sector peers before judging valuation or financial health.

Over the past year, CSCI's other current assets moved from $990K to $2.6M — a 158.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in COSCIENS Biopharma's operating scale or balance-sheet position.

A other current assets figure of $2.6M for CSCI is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting CSCI's other current assets ($2.6M), review year-over-year change from $990K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.